Pepto Bismol

Search documents
Procter & Gamble beats estimates but warns tariffs will start to weigh on earnings
CNBC· 2025-07-29 11:42
Core Insights - Procter & Gamble reported quarterly results that exceeded Wall Street expectations but provided fiscal year 2026 guidance that includes a $1 billion impact from higher tariff costs [1][3]. Financial Performance - For fiscal fourth quarter, Procter & Gamble reported net income of $3.62 billion, or $1.48 per share, compared to $3.14 billion, or $1.27 per share, a year earlier [4]. - Net sales increased by 2% to $20.89 billion, with organic sales also rising by 2% [5][7]. - Earnings per share of $1.48 surpassed the expected $1.42 [7]. Future Guidance - The company anticipates fiscal year 2026 sales growth between 1% and 5%, with earnings per share projected in the range of $6.83 to $7.09 [3]. - The guidance includes an estimated headwind of 39 cents per share for fiscal 2026, equating to a 6% drag on core earnings per share growth due to tariffs, unfavorable commodity costs, and higher net interest expenses [3]. Management Changes - CEO Jon Moeller announced that he will transition to the role of executive chairman effective January 1, with Shailesh Jejurikar set to replace him as CEO [2]. Market Reactions - Analysts had expected revenue growth of 3.1% and earnings per share of $6.99 for fiscal year 2026 [4]. - The company's stock has declined approximately 6% year to date, with concerns raised by analysts regarding soft organic sales and share losses within online retail [6].